Location: Home
  • search
  • go
  • Relate News
  • 1/18/2018Hua Medicine Mulls Hong Kong IPO as Diabetes Drug Enters Crucial Clini...
  • 1/18/2018Xbrane, CR Pharma Sign Letter of Intent for Lucentis Biosimilar in Chi...
  • 1/18/2018Suven Granted A Patent in China for NCEs Targeting Neuro Disorders
  • 1/18/2018Eisai Completes Construction of OSD Production Facility in China
  • 1/18/2018New Opportunities in Emerging Markets
  • 1/17/2018Amarin Announces Commencement of VASCEPA Clinical Development in Mainl...
  • 1/17/2018Innovent eyes IPO Later This Year, Possibly in the U.S.
  • 1/17/2018First Chronic HepB Patient Dosed in China in Transgene's Phase 1 Trial...
  • 1/17/2018China's Medical Representative Registration System: Action Items for P...
  • 1/17/20183SBio Licenses Mainland China Rights of Toray's Antipruritic Agent TRK...
  • 1/16/2018Clinical Trials Registered on the CDE Platform Rebound to a New Peak i...
  • 1/16/2018Data Snapshot: Overseas Out-licensing Deals of Novel Drugs Developed i...
  • 1/16/2018Data Snapshot: 41 Domestic Pharma Companies Launching A-Share IPOs in ...
  • 1/15/2018Overview of Chinese Drug Approvals in 2017
  • 1/15/2018Type 1 Diabetes on the Rise in China, Most New Cases in Adults
  • 1/15/2018CFDA Releases List of Newly Approved Professional Journals Approved fo...
  • 1/15/2018CDE Publishes Notice for Office Move
  • 1/12/2018BeiGene and Mirati Announce Exclusive License Agreement for Sitravatin...
  • 1/12/2018Hengrui and Arcutis Announce Partnership for Novel Immune-Mediated Der...
  • 1/12/2018Ferring and the Chinese Academy of Sciences Collaborate to Advance Res...
  • 1/11/2018China's Recent Development on Granting Biological Sequence Claims
  • 1/11/2018CFDA Seeks Comments on the Amendments of Administrative Measures for D...
  • 1/11/2018Recent Executive Moves
  • 1/11/2018Ten Contemporary Chinese Biopharma Industry Predictions in 2018
  • 1/11/2018Fosun's Wanbang Pharma and Bial Enter Exclusive Licensing Agreement fo...
  • 1/10/2018Data Snapshot: Chinese Hospital Consumption of Cholesterol-Reduction D...
  • 1/10/2018Indigenously-developed Class 1 New Chemical Drugs Approved in China 20...
  • 1/10/2018CPIIC: Chinese Urban Hospital Drug Market Expected to be Flat in 2017
  • 1/10/2018Numerous Provinces Expand Disease Group-Based BMI Payment Scheme at th...
  • 1/9/2018Sinobioway Sunterra Biotech to Initiate Trial of Two AB-CAR-T Candidat...
  • Page:282/720 Total number of articles:21580: [First][<<] [280] [281] [282] [283] [284] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group